Document Detail


Estimating antihypertensive effects of combination therapy in an observational study using marginal structural models.
MedLine Citation:
PMID:  19827055     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The evaluation of the antihypertensive effect of multiple antihypertensive drugs using data from an observational study requires adjustment for time-dependent confounders. Marginal structural models (MSMs) have been proposed to address this type of confounding through inverse probability weighting. Generally, the probabilities are estimated using logistic regression models that assume linearity between the logistic link and the predictors, but the linearity might be inaccurate. In this article, we proposed MSMs to assess the blood pressure-lowering effects of combination therapy with olmesartan medoxomil (OLM) plus calcium channel blockers (CCB) (OLM+CCB) in an observational study of OLM, and extended estimation methods of the probabilities for the MSMs using generalized additive models (GAMs). The estimation using GAMs was suggested to improve the balance of the distributions of confounder values between the therapy groups in the pseudo-population. We obtained estimated changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) for OLM+CCB combination therapy after 12 wk compared with OLM monotherapy of -4.3 mmHg (95% confidence interval (CI): -7.7 and -0.9 mmHg) and -2.9 mmHg (95% CI: -5.1 and -0.7 mmHg), respectively. The estimated target BP (SBP<140 mmHg and DBP<90 mmHg) achievement rates for OLM+CCB combination therapy and OLM monotherapy were 62.0 and 46.7%, respectively. The results of the MSMs were closer to those in the randomized controlled trial, such as the combination of OLM and amlodipine besylate in controlling high blood pressure study, than those of conventional methods. The proposed MSMs provided useful information to evaluate the effects of combination therapy of antihypertensive drugs in the context of an observational study.
Authors:
Masahiro Sugihara; Toshio Kushiro; Ikuo Saito; Yasuyuki Matsushita; Katsutoshi Hiramatsu
Related Documents :
9660525 - Morbidity and mortality with dihydropyridines.
12003705 - Resistant hypertension.
12461305 - Effectiveness of the electronic medical record in improving the management of hypertens...
12131525 - Survey on treatment of hypertension and implementation of world health organization/int...
8910175 - Effects of hemodilution during controlled hypotension of hepatic, renal, and pancreatic...
1913785 - Hemodynamic effects of prostaglandin e1 in patients with congenital heart disease and p...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biometrical journal. Biometrische Zeitschrift     Volume:  51     ISSN:  1521-4036     ISO Abbreviation:  Biom J     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-26     Completed Date:  2010-01-06     Revised Date:  2013-08-15    
Medline Journal Info:
Nlm Unique ID:  7708048     Medline TA:  Biom J     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  789-800     Citation Subset:  IM    
Affiliation:
Department of Industrial Engineering and Management, Tokyo Institute of Technology, 2-12-1 O-okayama, Meguro-ku, Tokyo 152-8552, Japan. Sugihara.Masahiro.e5@daiichisankyo.co.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / administration & dosage*
Biometry / methods*
Blood Pressure / drug effects
Calcium Channel Blockers / administration & dosage
Cohort Studies
Drug Therapy, Combination
Humans
Hypertension / drug therapy,  physiopathology
Imidazoles / administration & dosage
Logistic Models
Models, Statistical
Probability
Prospective Studies
Randomized Controlled Trials as Topic / statistics & numerical data
Tetrazoles / administration & dosage
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Calcium Channel Blockers; 0/Imidazoles; 0/Tetrazoles; 6M97XTV3HD/olmesartan medoxomil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  How does The Journal of Pathology deal with conflict of interest?
Next Document:  Neighborhood dependence in bayesian spatial models.